Embryo Ventures
Pre-seed to Series A investor in health and everyday-living infrastructure technology.
- Venture capital
- London
- Type
- Venture capital
- Based in
- London
- Stages
- Pre-seed, Seed
- Sector focus
- Insurtech, Healthtech, Climate & Energy, Proptech, Mobility
- Cheque size
- €100k–€1.5M
- Fund size
- Undisclosed
- Website
- embryoventures.com
Embryo Ventures is an early-stage venture firm based in Mayfair, London, with a second office in Berlin. It invests from pre-product and pre-revenue through to commercial launch, covering pre-seed to Series A.
Its thesis has two strands: health, spanning clinical and consumer technology for recovery, wellness and performance; and the systems that shape daily life, including connectivity, mobility, care, safety and the built environment. The firm invests mainly in the UK, Europe and the US, with occasional deals elsewhere. Directories report cheques from about $10,000 up to $1m.
← All investors · Is this your organisation? Request an update
More investors in the directory
The Craftory
Purpose-driven consumer packaged goods brands with category-changing potential
Symvan Capital
EIS and SEIS funds backing B2B SaaS and technology companies from seed to exit
Grafton Capital
Growth capital for European software, AI and tech-enabled businesses
Blackfinch Ventures
EIS and VCT investment in early and growth-stage UK technology businesses
The Conduit Connect
Impact-led UK startups from pre-seed to Series A in climate, health and financial resilience
TrueSight Ventures
Angel-sized cheques at pre-seed and seed, sector-agnostic, into technology companies
Subscribe to Newsletter
Join me on this exciting journey as we explore the boundless world of web design together.